SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-005491
Filing Date
2017-02-02
Accepted
2017-02-02 09:31:32
Documents
54
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v457646_10q.htm 10-Q 296293
2 EXHIBIT 31.1 v457646_ex31-1.htm EX-31.1 10153
3 EXHIBIT 31.2 v457646_ex31-2.htm EX-31.2 10185
4 EXHIBIT 32.1 v457646_ex32-1.htm EX-32.1 5124
5 EXHIBIT 32.2 v457646_ex32-2.htm EX-32.2 5162
  Complete submission text file 0001144204-17-005491.txt   3160546

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT antb-20161231.xml EX-101.INS 544610
7 XBRL TAXONOMY EXTENSION SCHEMA antb-20161231.xsd EX-101.SCH 42221
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE antb-20161231_cal.xml EX-101.CAL 31214
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE antb-20161231_def.xml EX-101.DEF 262331
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE antb-20161231_lab.xml EX-101.LAB 301083
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antb-20161231_pre.xml EX-101.PRE 287109
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54495 | Film No.: 17566996
SIC: 2834 Pharmaceutical Preparations